Protalix BioTherapeutics/$PLX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Protalix BioTherapeutics
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
- Ticker
- $PLX
- Sector
- Health
- Primary listing
- AMEX
- Employees
- 226
- Headquarters
- Hackensack, United States
- Website
- www.protalix.com
PLX Metrics
BasicAdvanced
$205M
10.74
$0.24
0.02
-
Price and volume
Market cap
$205M
Beta
0.02
52-week high
$3.19
52-week low
$1.65
Average daily volume
790K
Financial strength
Current ratio
2.938
Quick ratio
1.821
Long term debt to equity
0.106
Total debt to equity
0.129
Interest coverage (TTM)
18.97%
Profitability
EBITDA (TTM)
24.86
Gross margin (TTM)
45.77%
Net profit margin (TTM)
23.50%
Operating margin (TTM)
28.89%
Effective tax rate (TTM)
19.26%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
15.42%
Return on equity (TTM)
31.23%
Valuation
Price to earnings (TTM)
10.743
Price to revenue (TTM)
2.51
Price to book
2.87
Price to tangible book (TTM)
2.87
Price to free cash flow (TTM)
26.388
Free cash flow yield (TTM)
3.79%
Free cash flow per share (TTM)
0.096
Growth
Revenue change (TTM)
30.14%
Earnings per share change (TTM)
205.32%
3-year revenue growth (CAGR)
6.12%
10-year revenue growth (CAGR)
35.78%
3-year earnings per share growth (CAGR)
32.09%
10-year earnings per share growth (CAGR)
-26.28%
What the Analysts think about PLX
Analyst ratings (Buy, Hold, Sell) for Protalix BioTherapeutics stock.
Analyst projections of the future price of Protalix BioTherapeutics stock.
PLX Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
Funds containing PLX
Fund name | Fund size | $PLX weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.00% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.